Cargando…

Mechanisms of Drug Resistance in Ovarian Cancer and Associated Gene Targets

SIMPLE SUMMARY: When tumors become resistant to chemotherapeutics, alternative treatment strategies must be explored. Gene targeting provides a personalized and molecular approach to tackling chemoresistance in ovarian cancer. However, to advance the current landscape of gene targeting in ovarian ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alatise, Kharimat Lora, Gardner, Samantha, Alexander-Bryant, Angela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777152/ https://www.ncbi.nlm.nih.gov/pubmed/36551731 http://dx.doi.org/10.3390/cancers14246246

Ejemplares similares

Fusogenic peptide delivery of bioactive siRNAs targeting CSNK2A1 for treatment of ovarian cancer
por: Samec, Timothy, et al.
Publicado: (2022)

Nano-Based Drug Delivery and Targeting to Overcome Drug Resistance of Ovarian Cancers
por: McFadden, Melayshia, et al.
Publicado: (2021)

Targeting Nrf2 may reverse the drug resistance in ovarian cancer
por: Li, Danjie, et al.
Publicado: (2021)

Mechanisms of resistance to EGFR-targeted drugs: lung cancer
por: Morgillo, Floriana, et al.
Publicado: (2016)

Targeted Therapy and Mechanisms of Drug Resistance in Breast Cancer
por: Kinnel, Briana, et al.
Publicado: (2023)

Mechanisms of chemotherapy resistance in ovarian cancer
por: Ortiz, Mylena, et al.
Publicado: (2022)

Cellular Mechanism of Gene Mutations and Potential Therapeutic Targets in Ovarian Cancer
por: Guo, Tao, et al.
Publicado: (2021)

Ovarian cancer: epigenetics, drug resistance, and progression
por: Xie, Weiwei, et al.
Publicado: (2021)

Targeting of topoisomerases for prognosis and drug resistance in ovarian cancer
por: Bai, Yang, et al.
Publicado: (2016)

Targeting MAPK Signaling in Cancer: Mechanisms of Drug Resistance and Sensitivity
por: Lee, Shannon, et al.
Publicado: (2020)

Drug resistance mechanisms of cancer stem-like cells and their therapeutic potential as drug targets
por: Murayama, Takahiko, et al.
Publicado: (2019)

Non-Small Cell Lung Cancer Targeted Therapy: Drugs and Mechanisms of Drug Resistance
por: Wu, Jiajia, et al.
Publicado: (2022)

Mechanisms of Resistance to Chemotherapy in Breast Cancer and Possible Targets in Drug Delivery Systems
por: Lainetti, Patrícia de Faria, et al.
Publicado: (2020)

Molecular mechanisms targeting drug-resistance and metastasis in colorectal cancer: Updates and beyond
por: Al Bitar, Samar, et al.
Publicado: (2023)

Piperine Targets Different Drug Resistance Mechanisms in Human Ovarian Cancer Cell Lines Leading to Increased Sensitivity to Cytotoxic Drugs
por: Wojtowicz, Karolina, et al.
Publicado: (2021)

Identification of genes associated with platinum drug sensitivity and resistance in human ovarian cancer cells
por: Roberts, D, et al.
Publicado: (2005)

Individualization in the first-line treatment of advanced ovarian cancer based on the mechanism of action of molecularly targeted drugs
por: Nakai, Hidekatsu, et al.
Publicado: (2022)

Targeting Cancer Stem Cells to Overcome Therapy Resistance in Ovarian Cancer
por: Muñoz-Galván, Sandra, et al.
Publicado: (2020)

PARP inhibitors in ovarian cancer: Sensitivity prediction and resistance mechanisms
por: Jiang, Xuan, et al.
Publicado: (2019)

Molecular mechanisms of platinum-based chemotherapy resistance in ovarian cancer
por: Yang, Ling, et al.
Publicado: (2022)

PTTG: an important target gene for ovarian cancer therapy
por: Panguluri, Siva Kumar, et al.
Publicado: (2008)

An Overview of Candidate Therapeutic Target Genes in Ovarian Cancer
por: Alexandrova, Elena, et al.
Publicado: (2020)

Emerging targets in cancer drug resistance
por: Kumar, Shashank, et al.
Publicado: (2019)

Drug-Resistance Mechanism and New Targeted Drugs and Treatments of Relapse and Refractory DLBCL
por: Zhang, Jing, et al.
Publicado: (2023)

Emerging insights of tumor heterogeneity and drug resistance mechanisms in lung cancer targeted therapy
por: Lim, Zuan-Fu, et al.
Publicado: (2019)

Drugging the Epigenome: Overcoming Resistance to Targeted and Immunotherapies in Melanoma
por: Hanly, Ailish, et al.
Publicado: (2021)

Insight into the role of p62 in the cisplatin resistant mechanisms of ovarian cancer
por: Yan, Xiao-Yu, et al.
Publicado: (2020)

Patient selection and targeted treatment in the management of platinum-resistant ovarian cancer
por: Leamon, Christopher P, et al.
Publicado: (2013)

Increased Expression of Several Collagen Genes is Associated with Drug Resistance in Ovarian Cancer Cell Lines
por: Januchowski, Radosław, et al.
Publicado: (2016)

Big data-based identification of methylated genes associated with drug resistance and prognosis in ovarian cancer
por: Yan, Bingbing, et al.
Publicado: (2020)

Understanding and targeting resistance mechanisms in cancer
por: Lei, Zi‐Ning, et al.
Publicado: (2023)

Targeting hedgehog-driven mechanisms of drug-resistant cancers
por: Miller, Jade S., et al.
Publicado: (2023)

Recent Progress in Gene Therapy for Ovarian Cancer
por: Áyen, Ángela, et al.
Publicado: (2018)

Roles of Sorcin in Drug Resistance in Cancer: One Protein, Many Mechanisms, for a Novel Potential Anticancer Drug Target
por: Battista, Theo, et al.
Publicado: (2020)

Epigenetic Regulation of Cancer-Associated Genes in Ovarian Cancer
por: Kwon, Mi Jeong, et al.
Publicado: (2011)

Targeted treatment of recurrent platinum-resistant ovarian cancer: current and emerging therapies
por: Mantia-Smaldone, Gina M, et al.
Publicado: (2010)

How Does Endometriosis Lead to Ovarian Cancer? The Molecular Mechanism of Endometriosis-Associated Ovarian Cancer Development
por: Yachida, Nozomi, et al.
Publicado: (2021)

Epigenetic Mechanisms and Therapeutic Targets in Chemoresistant High-Grade Serous Ovarian Cancer
por: Matthews, Bayley G., et al.
Publicado: (2021)

UPR-induced ovarian cancer cell fusion: a mechanism favoring drug resistance?
por: Husein, Melisa, et al.
Publicado: (2023)

Antiangiogenic Strategies in Epithelial Ovarian Cancer: Mechanism, Resistance, and Combination Therapy
por: Jin, Chengwen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t9dma9e2eeop7ongo1f2ffemae